Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomonitoring and Identification of Predictive Biomarkers of Response, Toxicity and Risk of Relapse After CAR-T Cells in B-cell Lymphomas and Multiple Myeloma

NCT07852377 is registered in ClinicalTrials.gov with Centre Henri Becquerel as lead sponsor.

NCT NCT07852377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07852377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomonitoring and Identification of Predictive Biomarkers of Response, Toxicity and Risk of Relapse After CAR-T Cells in B-cell Lymphomas and Multiple Myeloma
Lead sponsor
Centre Henri Becquerel
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 18, 2026
Completion date
November 2, 2028
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b cell lymphoma, multiple mieloma